Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development
- PMID: 3923100
Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development
Abstract
Ontogenic development and the lymphokine responsiveness of human NK cell activity against K562 target cells in peripheral blood lymphocytes were evaluated in fetuses, premature infants, and term neonates by using a 4-hr 51Cr-release assay. Basal NK activity and NK boosting by lymphokines were comparatively assayed after an 18-hr incubation with medium alone, recombinant human IFN-gamma (1000 U/ml), and recombinant human IL 2 (25 U/ml), respectively. Lymphocytes from 20-wk-old fetuses lacked NK cell activity even after the pretreatment with IFN-gamma. Low, but significant levels of NK activity and NK boosting by IFN-gamma were observed in premature infants after 27 wk of gestation, with a progressive intrauterine maturation of these activities. Both basal NK activity and NK boosting by IFN-gamma in term neonates were still lower than those of adult controls. The grade of NK boosting by IFN-gamma appeared to depend on the development of basal NK activity. Contrary to IFN-gamma, IL 2 could induce marked NK activity even in 20-wk-old fetuses who lacked both basal and IFN-gamma inducible NK activities. NK boosting by IL 2 was much more efficient than that by IFN-gamma at any period of human life. The facts that IL 2-induced NK boosting could occur without any appreciable production of IFN-gamma in neonatal lymphocytes, and that ample neutralizing doses of anti-IFN-gamma antibody hardly suppressed IL 2-mediated NK boosting even in adult lymphocytes, indicated that the effect of IL 2 on NK boosting might be independent of IFN-gamma production. On the basis of the ontogenic differences in the development of the lymphokine responsiveness of NK cell activity and on the different NK boosting mechanisms of these lymphokines it was suggested that so-called human "pre-NK cells" might be divided into IFN-gamma sensitive and IL 2-sensitive cells. Whether these cell populations belong to different cell lineages or different maturation stages of the same cell line, however, remains unsettled.
Similar articles
-
Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.J Immunol. 1985 Mar;134(3):1503-7. J Immunol. 1985. PMID: 3918102
-
Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.J Immunol. 1984 Aug;133(2):779-83. J Immunol. 1984. PMID: 6203980
-
Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).J Immunol. 1985 May;134(5):3124-9. J Immunol. 1985. PMID: 2984283
-
Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.Crit Rev Immunol. 1993;13(1):1-34. Crit Rev Immunol. 1993. PMID: 8466640 Review.
-
Comparative evaluation of multiple lymphoid and recombinant human interleukin-2 preparations.J Biol Response Mod. 1986 Feb;5(1):85-107. J Biol Response Mod. 1986. PMID: 3514800 Review.
Cited by
-
Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins.J Exp Med. 1992 Apr 1;175(4):1055-66. doi: 10.1084/jem.175.4.1055. J Exp Med. 1992. PMID: 1372642 Free PMC article.
-
Human umbilical cord blood (HUCB) cells for central nervous system repair.Neurotox Res. 2003;5(5):355-68. doi: 10.1007/BF03033155. Neurotox Res. 2003. PMID: 14715454 Review.
-
A strategy for evaluating lymphokine activation and novel monoclonal antibodies in antibody-dependent cell-mediated cytotoxicity and effector cell retargeting assays.Cancer Immunol Immunother. 1990;31(4):207-12. doi: 10.1007/BF01789170. Cancer Immunol Immunother. 1990. PMID: 2379218 Free PMC article.
-
Paradoxical enhancement of interleukin-2-mediated cytotoxicity against K562 cells by addition of a low dose of methotrexate.Cancer Immunol Immunother. 1990;32(1):8-12. doi: 10.1007/BF01741718. Cancer Immunol Immunother. 1990. PMID: 2149670 Free PMC article.
-
Cytotoxic in vitro function in the lymphoproliferative disease of granular lymphocytes.Clin Exp Immunol. 1987 Oct;70(1):222-30. Clin Exp Immunol. 1987. PMID: 3121223 Free PMC article.